Versatile Emission Computed Tomography (VECTor) combines microPET and microSPECT.


June 2, 2010 - TU Delft and Molecular Imaging Labs (MI Labs) have succeeded in combining two forms of medical imaging techniques into one piece of equipment. The two techniques are known as micro positron emission tomography (microPET) and micro single photon emission computed tomography (microSPECT).

These techniques are useful for cancer research for SPECT and PET performed simultaneously, which delivers even higher resolution than traditional microSPECT and microPET.

The new device, Versatile Emission Computed Tomography (VECTor), is designed for use in fundamental research into the functioning of cells and organs. It can show functional details smaller than half a millimeter.

PET and SPECT are also commonly used to carry out fundamental research into living cells and disease mechanisms or to develop better methods of diagnosis and treatment. The equipment that was developed at TU Delft and MI Labs designed for fundamental research using experimental animal models. The combined PET/SPECT apparatus offers extremely high resolution, reduces use of laboratory animals and also offers financial savings when carrying out research in this area. Previously, both types of equipment would have had to be bought separately and less information could be gained from each individual animal.

The U-SPECT, and later the combined U-SPECT/PET scanner, is currently being used for research using mice. The challenge for scientists is to build a hybrid SPECT/CT that can be used on humans to detect tumors at an early stage.

For more information: www.tudelft.nl


Related Content

News | Radiopharmaceuticals and Tracers

April 5, 2024 — RLS Radiopharmacies, America’s only Joint Commission-accredited radiopharmacy network, today announced ...

Time April 05, 2024
arrow
News | FDA

January 23, 2024 — Siemens Healthineers announces the Food and Drug Administration (FDA) clearance of syngo Virtual ...

Time January 23, 2024
arrow
News | Radiation Therapy

January 19, 2024 — Treating tumors is a global health issue. In radiotherapy, radiation is used to destroy tumor cells ...

Time January 19, 2024
arrow
Feature | PET-CT | By Melinda Taschetta-Millane

According to research conducted by Polaris Market Research, the global positron emission tomography (PET)/computed ...

Time January 17, 2024
arrow
News | Prostate Cancer

January 5, 2024 — Perspective Therapeutics, Inc., announced that it has entered into a patent license agreement with ...

Time January 05, 2024
arrow
News | Radiopharmaceuticals and Tracers

December 6, 2023 — Philochem AG, a wholly owned subsidiary of Philogen S.p.A., and Blue Earth Diagnostics, a Bracco ...

Time December 06, 2023
arrow
News | RSNA

December 1, 2023 — In today's healthcare environment, the industry faces various pressing challenges. The magnetic ...

Time December 01, 2023
arrow
News | Quality Assurance (QA)

November 25, 2023 — Mirion announced that it will debut the new Instadose VUE personal dosimeter, from its Dosimetry ...

Time November 25, 2023
arrow
News | PET-CT

November 22, 2023 — Siemens Healthineers has announced the U.S. Food and Drug Administration (FDA) clearance of the ...

Time November 22, 2023
arrow
News | Artificial Intelligence

November 21, 2023 — Heuron, a medical AI (artificial intelligence) imaging software solution company, under the ...

Time November 21, 2023
arrow
Subscribe Now